Vilin Bio Med Limited (NSE:VILINBIO)
44.35
-0.85 (-1.88%)
Jun 17, 2026, 11:14 AM IST
Vilin Bio Med Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 14.7 | 0.56 | 60.49 | 0.35 | 0.39 |
Cash & Short-Term Investments | 14.7 | 0.56 | 60.49 | 0.35 | 0.39 |
Cash Growth | 2520.14% | -99.07% | 17434.49% | -11.54% | -16.13% |
Accounts Receivable | 159.56 | 63.06 | 56.84 | 56.01 | 77.87 |
Other Receivables | - | - | - | - | 9.19 |
Receivables | 163.89 | 69.46 | 67.97 | 62.56 | 92.72 |
Inventory | 72.15 | 44.12 | 44.68 | 8.79 | 22.84 |
Other Current Assets | 23.09 | 11.47 | 13.02 | 8.85 | 3.14 |
Total Current Assets | 273.83 | 125.61 | 186.16 | 80.54 | 119.09 |
Property, Plant & Equipment | 28.65 | 28.53 | 13.83 | 15.12 | 16.5 |
Long-Term Accounts Receivable | 46.94 | 72.56 | 77.45 | 71.61 | - |
Other Long-Term Assets | - | - | - | - | -0 |
Total Assets | 349.42 | 277.28 | 324.04 | 176.76 | 135.58 |
Accounts Payable | 33.55 | 13.89 | 19.53 | 11.89 | 6.41 |
Accrued Expenses | - | - | - | 2.76 | 1.38 |
Current Portion of Long-Term Debt | 2.06 | 25.73 | 66.21 | 45 | 45.66 |
Current Income Taxes Payable | - | 5.69 | 5.69 | 5.28 | 0.25 |
Other Current Liabilities | 28.81 | 0.39 | 1.3 | 0.03 | - |
Total Current Liabilities | 64.42 | 45.7 | 92.74 | 64.97 | 53.7 |
Long-Term Debt | - | - | 2.09 | 4.31 | 7.34 |
Long-Term Deferred Tax Liabilities | - | 0.94 | 0.82 | 0.7 | 0.58 |
Other Long-Term Liabilities | 1.28 | - | -0 | -0 | - |
Total Liabilities | 65.7 | 46.64 | 95.64 | 69.98 | 61.62 |
Common Stock | 152.5 | 139.5 | 139.5 | 99.5 | 33 |
Additional Paid-In Capital | - | 80 | 80 | - | - |
Retained Earnings | - | 8.88 | 6.64 | 5.02 | 38.71 |
Comprehensive Income & Other | 131.22 | 2.26 | 2.26 | 2.26 | 2.26 |
Shareholders' Equity | 283.72 | 230.64 | 228.4 | 106.78 | 73.96 |
Total Liabilities & Equity | 349.42 | 277.28 | 324.04 | 176.76 | 135.58 |
Total Debt | 2.06 | 25.73 | 68.3 | 49.31 | 53 |
Net Cash (Debt) | 12.64 | -25.17 | -7.81 | -48.97 | -52.61 |
Net Cash Per Share | 0.90 | -1.80 | -0.56 | -4.92 | -6.38 |
Filing Date Shares Outstanding | 14.37 | 13.95 | 13.95 | 9.95 | 8.25 |
Total Common Shares Outstanding | 14.37 | 13.95 | 13.95 | 9.95 | 8.25 |
Working Capital | 209.41 | 79.91 | 93.42 | 15.58 | 65.39 |
Book Value Per Share | 19.75 | 16.53 | 16.37 | 10.73 | 8.96 |
Tangible Book Value | 283.72 | 230.64 | 228.4 | 106.78 | 73.96 |
Tangible Book Value Per Share | 19.75 | 16.53 | 16.37 | 10.73 | 8.96 |
Land | - | 2.12 | 2.12 | 2.12 | 2.12 |
Buildings | - | 34.9 | 34.9 | 34.9 | 34.9 |
Machinery | - | 56.91 | 56.85 | 56.84 | 56.54 |
Construction In Progress | - | 15.68 | - | - | - |